• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶5在缺氧条件下通过增加缺氧诱导因子-1α的转录促进肝细胞癌的迁移和侵袭。

Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition.

作者信息

Ye Ming, Fang Zejun, Gu Hongqian, Song Rui, Ye Jiangwei, Li Hongzhang, Wu Zhiguang, Zhou Shenghui, Li Peng, Cai Xiang, Ding Xiaokun, Yu Songshan

机构信息

1 Department of General Surgery, Sanmen People's Hospital of Zhejiang, Sanmen, China.

2 Central Laboratory, Sanmen People's Hospital of Zhejiang, Sanmen, China.

出版信息

Tumour Biol. 2017 Jun;39(6):1010428317705034. doi: 10.1177/1010428317705034.

DOI:10.1177/1010428317705034
PMID:28653891
Abstract

Hypoxia plays a critical role in the progression and metastasis of hepatocellular carcinoma by activating the key transcription factor, hypoxia-inducible factor-1. This study aims to identify the novel mechanisms underlying the dysregulation of hypoxia-inducible factor-1α in hepatocellular carcinoma. We found that histone deacetylase 5, a highly expressed histone deacetylase in hepatocellular carcinoma, strengthened the migration and invasion of hepatocellular carcinoma cells under hypoxia but not normoxia condition. Furthermore, histone deacetylase 5 induced the transcription of hypoxia-inducible factor-1α by silencing homeodomain-interacting protein kinase-2 expression, which was also dependent on hypoxia. And then knockdown of hypoxia-inducible factor-1α decreased the expressions of mesenchymal markers, N-cadherin, and Vimentin, as well as matrix metalloproteinases, MMP7 and MMP9; however, the epithelial marker, E-cadherin, increased. Phenotype experiments showed that the migration and invasion of hepatocellular carcinoma cells were impaired by knockdown of histone deacetylase 5 or hypoxia-inducible factor-1α but rescued when eliminating homeodomain-interacting protein kinase-2 in hepatocellular carcinoma cells, which suggested the critical role of histone deacetylase 5-homeodomain-interacting protein kinase-2-hypoxia-inducible factor-1α pathway in hypoxia-induced metastasis. Finally, clinical analysis confirmed the positive correlation between histone deacetylase 5 and hypoxia-inducible factor-1α in hepatocellular carcinoma specimens and a relatively poor prognosis for the patients with high levels of histone deacetylase 5 and hypoxia-inducible factor-1α. Taken together, our findings demonstrated a novel mechanism underlying the crosstalk between histone deacetylase 5 and hypoxia-inducible factor-1 in hepatocellular carcinoma.

摘要

缺氧通过激活关键转录因子缺氧诱导因子-1在肝细胞癌的进展和转移中起关键作用。本研究旨在确定肝细胞癌中缺氧诱导因子-1α失调的新机制。我们发现,组蛋白去乙酰化酶5是肝细胞癌中高表达的组蛋白去乙酰化酶,在缺氧而非常氧条件下增强了肝癌细胞的迁移和侵袭能力。此外,组蛋白去乙酰化酶5通过沉默同源结构域相互作用蛋白激酶-2的表达诱导缺氧诱导因子-1α的转录,这也依赖于缺氧。然后敲低缺氧诱导因子-1α降低了间充质标志物N-钙黏蛋白和波形蛋白以及基质金属蛋白酶MMP7和MMP9的表达;然而,上皮标志物E-钙黏蛋白增加。表型实验表明,敲低组蛋白去乙酰化酶5或缺氧诱导因子-1α会损害肝癌细胞的迁移和侵袭能力,但在肝癌细胞中消除同源结构域相互作用蛋白激酶-2时则会恢复,这表明组蛋白去乙酰化酶5-同源结构域相互作用蛋白激酶-2-缺氧诱导因子-1α通路在缺氧诱导的转移中起关键作用。最后,临床分析证实了肝细胞癌标本中组蛋白去乙酰化酶5与缺氧诱导因子-1α之间的正相关,以及组蛋白去乙酰化酶5和缺氧诱导因子-1α水平高的患者预后相对较差。综上所述,我们的研究结果揭示了肝细胞癌中组蛋白去乙酰化酶5与缺氧诱导因子-1之间相互作用的新机制。

相似文献

1
Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition.组蛋白去乙酰化酶5在缺氧条件下通过增加缺氧诱导因子-1α的转录促进肝细胞癌的迁移和侵袭。
Tumour Biol. 2017 Jun;39(6):1010428317705034. doi: 10.1177/1010428317705034.
2
RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.RNA干扰敲低缺氧诱导因子-1α可降低缺氧肝癌细胞的增殖、迁移和侵袭能力。
Cell Biochem Biophys. 2015 Apr;71(3):1677-84. doi: 10.1007/s12013-014-0390-x.
3
Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.缺氧诱导因子-1α对COX-2表达及上皮-间质转化的调控与肝细胞癌患者TACE术后预后不良相关。
Int J Oncol. 2016 May;48(5):2144-54. doi: 10.3892/ijo.2016.3421. Epub 2016 Mar 4.
4
Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.缺氧通过 HIF-1α 上调 Rab11 家族相互作用蛋白 4 以促进肝细胞癌的转移。
Oncogene. 2015 Dec 3;34(49):6007-17. doi: 10.1038/onc.2015.49. Epub 2015 Mar 9.
5
Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.缺氧诱导因子-1α(HIF-1α)和转移相关蛋白 2(MTA2)的相互作用环通过抑制 E-钙黏蛋白转录促进胰腺癌的进展。
J Pathol. 2018 Jul;245(3):349-360. doi: 10.1002/path.5089. Epub 2018 Jun 1.
6
PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.PROX1 通过上调低氧诱导因子 1α 的表达和蛋白稳定性促进肝癌转移。
Hepatology. 2013 Aug;58(2):692-705. doi: 10.1002/hep.26398.
7
Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.Wnt/β-catenin 信号通过与 hif-1α 信号的串扰增强肝癌缺氧诱导的上皮间质转化。
Carcinogenesis. 2013 May;34(5):962-73. doi: 10.1093/carcin/bgt027. Epub 2013 Jan 27.
8
Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.缺氧诱导因子 -1α 通过激活 SNAI1 诱导肝癌发生上皮间质转化。
BMC Cancer. 2013 Mar 9;13:108. doi: 10.1186/1471-2407-13-108.
9
The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.肝细胞癌中 HIF-1α 和 HIF-2α 的表达水平与包膜侵犯、门静脉癌栓和患者临床结局的相关性。
Jpn J Clin Oncol. 2014 Feb;44(2):159-67. doi: 10.1093/jjco/hyt194. Epub 2013 Dec 26.
10
The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.Aurora A 在缺氧诱导因子 1α 促进肝癌恶性表型中的作用。
Cell Cycle. 2013 Sep 1;12(17):2849-66. doi: 10.4161/cc.25916. Epub 2013 Aug 7.

引用本文的文献

1
Association of changes in expression of and genes after drug treatment with cancer cell line sensitivity to kinase inhibitors.药物处理后 和 基因表达变化与激酶抑制剂对癌细胞系敏感性的关系。
Epigenetics. 2024 Dec;19(1):2309824. doi: 10.1080/15592294.2024.2309824. Epub 2024 Feb 18.
2
The SMAD2/miR-4256/HDAC5/p16 signaling axis contributes to gastric cancer progression.SMAD2/miR-4256/HDAC5/p16 信号轴促进胃癌进展。
Oncol Res. 2023 Jun 27;31(4):515-541. doi: 10.32604/or.2023.029101. eCollection 2023.
3
Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies.
缺氧诱导因子在局部消融治疗下的肝细胞癌中的作用
Front Pharmacol. 2023 Feb 6;14:1086813. doi: 10.3389/fphar.2023.1086813. eCollection 2023.
4
Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma.缺氧诱导因子-1α:抑制肝细胞癌转移的关键靶点。
Oncol Lett. 2022 Jun 28;24(2):284. doi: 10.3892/ol.2022.13404. eCollection 2022 Aug.
5
Alternative splicing variant of NRP/B promotes tumorigenesis of gastric cancer.NRP/B 的剪接变体促进胃癌的肿瘤发生。
BMB Rep. 2022 Jul;55(7):348-353. doi: 10.5483/BMBRep.2022.55.7.034.
6
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.靶向特发性肺纤维化中的组蛋白去乙酰化酶:未来的治疗选择。
Cells. 2022 May 12;11(10):1626. doi: 10.3390/cells11101626.
7
Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer.肝癌中与代谢相关的表观遗传和免疫表观遗传重编程
Cancers (Basel). 2021 Oct 19;13(20):5250. doi: 10.3390/cancers13205250.
8
Insights Into the Function and Clinical Application of HDAC5 in Cancer Management.组蛋白去乙酰化酶5在癌症治疗中的功能及临床应用洞察
Front Oncol. 2021 Jun 10;11:661620. doi: 10.3389/fonc.2021.661620. eCollection 2021.
9
LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940.长链非编码RNA-CCDC144NL反义RNA1通过海绵吸附miR-940诱导WDR5表达促进肝细胞癌发展
J Hepatocell Carcinoma. 2021 May 3;8:333-348. doi: 10.2147/JHC.S306484. eCollection 2021.
10
Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma.组蛋白去乙酰化酶抑制剂用于克服转移性黑色素瘤对靶向治疗和免疫治疗的耐药性
Front Cell Dev Biol. 2020 Jun 17;8:486. doi: 10.3389/fcell.2020.00486. eCollection 2020.